Literature DB >> 24476429

Assessing the clinical benefits of lipid-disorder drugs.

William R Hiatt1, Robert J Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24476429     DOI: 10.1056/NEJMp1313866

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  An Uninformative Truth: The Logic of Amarin's Off-Label Promotion.

Authors:  Spencer Phillips Hey; Aaron S Kesselheim
Journal:  PLoS Med       Date:  2016-03-15       Impact factor: 11.069

2.  Efficacy and safety of a generic rosuvastatin in a real-world setting: prospective, observational clinical study in Lebanese patients.

Authors:  Mohamad Betto; Jocelyne Fares; Nada Saliba; Hajar Ballout
Journal:  Ann Saudi Med       Date:  2017 Sep-Oct       Impact factor: 1.526

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.